4826 | It has been a while but I am back. | kaiser | 09/28/2025 5:45:13 PM |
4261 | SUTI 0014 should be a nice mover from | kaiser | 02/19/2015 12:18:50 PM |
4260 | BRZL 001 buyers moving in | kaiser | 02/19/2015 10:22:04 AM |
4257 | VOIS 0013 looks ready to move | kaiser | 02/18/2015 3:20:07 PM |
4256 | VMGI 0005's going | kaiser | 02/18/2015 2:46:12 PM |
4255 | VMGI 0005 nice buys coming in | kaiser | 02/18/2015 2:29:58 PM |
4254 | SHMX 0004 X 0005 company should have an update | kaiser | 02/18/2015 11:28:00 AM |
4253 | SHMX 0006 hitting | kaiser | 02/17/2015 1:57:36 PM |
4252 | SHMX 0005 X 0006 | kaiser | 02/17/2015 1:38:29 PM |
4251 | SHMX 0004 X 0005 bid building | kaiser | 02/17/2015 12:13:57 PM |
4250 | SREH 0005 hitting | kaiser | 02/17/2015 11:05:54 AM |
4249 | SHMX 0004 X 0005 | kaiser | 02/17/2015 10:24:03 AM |
4248 | SHMX 0004 falling | kaiser | 02/17/2015 10:20:54 AM |
4247 | SHMX 0004 hitting | kaiser | 02/17/2015 10:16:35 AM |
4246 | KHGT 0013 | kaiser | 02/17/2015 9:34:07 AM |
4245 | SHMX 0003 X 0004 | kaiser | 02/17/2015 9:31:42 AM |
4244 | SREH 0005 company filings out last week. Company | kaiser | 02/17/2015 8:10:14 AM |
4243 | SREH 0004 X 0005 bid building | kaiser | 02/13/2015 3:01:25 PM |
4242 | SREH 0005 hitting | kaiser | 02/13/2015 2:32:10 PM |
4241 | CATA 0024 X 0026 | kaiser | 02/13/2015 2:19:35 PM |
4240 | KHGT 0017 X 0018 | kaiser | 02/13/2015 1:58:13 PM |
4239 | KHGT 0016 nice buys coming in | kaiser | 02/13/2015 1:56:14 PM |
4238 | LGBS 0005 | kaiser | 02/13/2015 11:00:30 AM |
4237 | LGBS 0004 hitting | kaiser | 02/13/2015 10:58:41 AM |
4236 | LGBS 0003 buyers moving in | kaiser | 02/13/2015 10:56:02 AM |
4235 | MCGI 0022 hitting | kaiser | 02/12/2015 3:48:58 PM |
4234 | CATA 002 X 0022 | kaiser | 02/12/2015 2:41:14 PM |
4233 | CATA 0016 X 0022 | kaiser | 02/12/2015 1:39:48 PM |
4232 | CATA 0019 | kaiser | 02/12/2015 1:09:12 PM |
4231 | CATA 0017 | kaiser | 02/12/2015 1:03:42 PM |
4230 | CATA 0014 X 0016 | kaiser | 02/12/2015 1:00:59 PM |
4229 | EVDR 0007 hitting | kaiser | 02/12/2015 12:23:31 PM |
4228 | EVDR 0006 X 0007 | kaiser | 02/12/2015 11:59:07 AM |
4227 | SREH 0005 hitting | kaiser | 02/12/2015 11:29:09 AM |
4226 | CATA 0014's going | kaiser | 02/12/2015 10:21:27 AM |
4225 | CATA 0014 nice hits coming in | kaiser | 02/11/2015 3:30:01 PM |
4224 | EVDR 0006 nice buying | kaiser | 02/11/2015 3:05:32 PM |
4223 | CATA 0011 X 0014 bidders moving | kaiser | 02/11/2015 2:49:50 PM |
4222 | CATA 0014 | kaiser | 02/11/2015 2:27:05 PM |
4221 | CATA 0013 buys coming in | kaiser | 02/11/2015 2:24:31 PM |
4220 | VOIS 0016 | kaiser | 02/11/2015 1:51:36 PM |
4219 | VOIS 0015 hitting | kaiser | 02/11/2015 1:47:58 PM |
4218 | MCGI 0016 X 0019 nice bid in | kaiser | 02/11/2015 1:40:28 PM |
4217 | VOIS 0014 X 0015 | kaiser | 02/11/2015 12:35:04 PM |
4216 | TOPZ 0016 nice buying. Looks | kaiser | 02/11/2015 12:21:56 PM |
4215 | VOIS 0014 | kaiser | 02/11/2015 11:58:07 AM |
4214 | VOIS 0012 X 0013 | kaiser | 02/11/2015 10:27:18 AM |
4213 | VOIS 0011 X 0012 | kaiser | 02/11/2015 10:09:21 AM |
4212 | VOIS 0011 | kaiser | 02/11/2015 9:33:29 AM |
4211 | MCGI 002 | kaiser | 02/10/2015 1:36:21 PM |
4210 | VOIS 0011 X 0012 | kaiser | 02/10/2015 12:12:54 PM |
Recent Articles
- Elevara Medicines Secures Funding to Revolutionize RA Treatment
- Exciting Breakthroughs in Precision Oncology by Onco3R Therapeutics
- Insights into Ringkjøbing Landbobank's Q3 Performance in 2025
- Intellistake Technologies Partners with Mycelium for AI Innovation
- Exploring Wealth Planning: Insights from Andy Garcia's Program
- Understanding the Global Impacts of EU's Circularity Regulation
- Berlin Heals Enhances Leadership with Dr. Eric Fain Addition
- Binance Revolutionizes Banking with Direct USD Transactions
- Global Gastronomy Unveiled at S.Pellegrino Competition Finale
- Discover the Remarkable Features of Huion Kamvas Pro 24 (Gen 3)
- Discover the Groundbreaking Features of Oticon Zeal™ Hearing Aid
- Transforming Pet Healthcare: Rise of Cancer Therapeutics
- Important Transaction Notifications from Company Managers
- Netflix's Leadership Stresses Building Over Buying Amid Merger Talks
- Work Medical Technology Soars 50% After Major Investment Deal
- General Motors Shifts Focus as BrightDrop Van Production Stops
- Raythink Technology Showcases Innovative Thermal Solutions
- LISCure BioSciences Achieves Milestone with Joint Health Probiotic
- Vantaan Energia Optimizes Energy Solutions with Elisa Gridle
- Tesla Analysts Predict Performance Ahead of Q3 Results
- Renalys Pharma Boosts Alport Syndrome Research Endeavors
- Newly Formed Nominating Committee for SciBase's 2026 Meeting
- Sweco's Groundbreaking Infrastructure Project to Control Flooding
- GBI Partners with Nokia for Enhanced Middle East Connectivity
- Hermès Shows Resilience with Steady Growth in Q3 2025
- Innovative Share Buy-Back by NB Private Equity Partners
- Foresight Group's Strategic Share Buyback Program Highlights
- Eurostar Partnering with Alstom for Next-Gen High-Speed Trains
- Solar A/S Strategically Expands with Sonepar Acquisition
- Boliden's Q3 2025: Exceptional Performance Metrics and Insights
- Boliden Q3 2025 Report: Promising Financial Performance
- Transforming Shanghai into a Leading Global Shipping Hub
- LNG2026 Conference: Key Sessions and Influential Speakers
- All Around Polymer Introduces Innovative Nylon Compounding Framework
- Shelf Intelligence: The Retail Revolution Transforming Shopping
- ACM Biolabs Unveils Promising Safety Data for ACM-CpG Therapy
- Bernie Sanders Critiques Jeff Bezos on Job Automation Push
- General Motors Faces EV Market Challenges Amid Industry Changes
- Beneficient Stock Sees Significant Overnight Growth Catalyst
- Sampo plc Announces Significant Share Buybacks for 2025
- Endeavour Mining's Recent Share Buyback Highlights Strategy
- FLSmidth Announces Successful Share Buy-Back Transactions
- Ringkjøbing Landbobank Provides Strong Q3 2025 Update
- Innovative Collaboration Elevates Electric Powertrain Benchmarking
- Promising Results for Novartis' Cosentyx in PMR Treatment
- Novartis Successfully Completes Hart-Scott-Rodino Waiting Period
- BAWAG Group Reports Strong Q3, Exceeding Performance Goals
- Ipsen Expands Oncology Pipeline with ImCheck Acquisition
- Sanofi's Efdoralprin Alfa: A Breakthrough in AATD Treatment
- Heineken N.V.: Navigating Challenges in Q3 Trading Update